Tag: neuralstem
Phase 2 clinical trial of NSI-189 in ischaemic stroke initiated
Neuralstem, Inc., a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, has announced the initiation...
NSI-566 stem cell therapy confers neurological improvement in spinal cord injury...
Intraspinal injections of human spinal cord-derived neural stem cells are well tolerated in a Phase I study of four patients with thoracic (T2–T12) ASIA-A...
